The structural elucidation of chiral rare-earth-based catalysts in asymmetric reactions holds significant importance as it is crucial for comprehending their operational mechanisms and for broadening their applications in the realm of asymmetric synthesis. Herein, a LaIII/(L3-RaMe3)2 complex was identified to be more active and enantioselective than LaIII/L3-RaMe3 in the asymmetric formal substitution of racemic 3-bromo-3-substituted oxindoles with TMSCN. The experimental studies and theoretical calculations disclosed that the partial dissociation of the chiral N,N′-dioxide ligand was involved in the catalytic process with LaIII/(L3-RaMe3)2. These insights provided a rationale for the remarkable effect of catalyst structures on the results and nonlinear effect observed in the current reaction system. This protocol offers a straightforward and efficient pathway to synthesize various chiral 3-cyano-3-substituted oxindoles (53 examples, up to 99% yield, 98% ee). In addition, the synthesis of a bioactive compound CRTH2 receptor antagonist and obvious inhibitory effect of several products on the viability of cancer cells demonstrate the potential utility of this methodology.
No takes yet. Share an insight, caveat, or question.
Zeng et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: